Andrew Park is currently the Associate Director, Clinical Operations Leader at Galapagos, a position they have held since 2025. Previously, Andrew served as the Site Management Lead at Alexion Pharmaceuticals, Inc. from 2020 to 2022, and as the Lead Clinical Research Associate/Clinical Site Lead at Novo Nordisk from 2017 to 2020. Andrew is also pursuing a degree at Boston University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices